These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 34923947)

  • 1. Natural Product-based Nanomedicine: Recent Advances and Issues for the Treatment of Alzheimer's Disease.
    Woon CK; Hui WK; Abas R; Haron MH; Das S; Lin TS
    Curr Neuropharmacol; 2022; 20(8):1498-1518. PubMed ID: 34923947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease.
    Li L; Zhang J; Huang X; Du J; Tu Z; Wu H; Liu X; Yuan M
    Curr Pharm Des; 2023; 29(2):95-115. PubMed ID: 36529920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
    Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
    J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Potential of Nanomedicine in Management of Alzheimer's Disease and Glioma.
    Anwar F; Al-Abbasi FA; Naqvi S; Sheikh RA; Alhayyani S; Asseri AH; Asar TO; Kumar V
    Int J Nanomedicine; 2023; 18():2737-2756. PubMed ID: 37250469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology in the diagnostic and therapy for Alzheimer's disease.
    Panghal A; Flora SJS
    Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130559. PubMed ID: 38191034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotherapeutics for Alzheimer's Disease with Preclinical Evaluation and Clinical Trials: Challenges, Promises and Limitations.
    Bukhari SNA
    Curr Drug Deliv; 2022; 19(1):17-31. PubMed ID: 34514990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
    Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
    Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease.
    Ling TS; Chandrasegaran S; Xuan LZ; Suan TL; Elaine E; Nathan DV; Chai YH; Gunasekaran B; Salvamani S
    Biomed Res Int; 2021; 2021():5550938. PubMed ID: 34285915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology to improve the Alzheimer's disease therapy with natural compounds.
    Ramalho MJ; Andrade S; Loureiro JA; do Carmo Pereira M
    Drug Deliv Transl Res; 2020 Apr; 10(2):380-402. PubMed ID: 31773421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting.
    Pathak K; Ahmad MZ; Saikia R; Pathak MP; Sahariah JJ; Kalita P; Das A; Islam MA; Pramanik P; Tayeng D; Abdel-Wahab BA
    Cent Nerv Syst Agents Med Chem; 2024 Mar; ():. PubMed ID: 38551038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer's Disease.
    Mazahir F; Yadav AK
    CNS Neurol Disord Drug Targets; 2023; 22(4):477-499. PubMed ID: 35450536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: review of current nanotechnological therapeutic strategies.
    Baranowska-Wójcik E; Szwajgier D
    Expert Rev Neurother; 2020 Mar; 20(3):271-279. PubMed ID: 31957510
    [No Abstract]   [Full Text] [Related]  

  • 13. Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer's Disease: Present Status and Future Opportunities.
    Ovais M; Zia N; Ahmad I; Khalil AT; Raza A; Ayaz M; Sadiq A; Ullah F; Shinwari ZK
    Front Aging Neurosci; 2018; 10():284. PubMed ID: 30405389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease.
    Wilson B; Geetha KM
    J Control Release; 2020 Sep; 325():25-37. PubMed ID: 32473177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery.
    Sharma HS; Castellani RJ; Smith MA; Sharma A
    Int Rev Neurobiol; 2012; 102():47-90. PubMed ID: 22748826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Nanotechnology: A Novel Therapeutic System for the Treatment of Alzheimer's Disease.
    Chauhan PS; Yadav D; Koul B; Mohanta YK; Jin JO
    Curr Drug Metab; 2020; 21(14):1144-1151. PubMed ID: 33234100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of nanomedicines for the treatment of Alzheimer's disease: Raison d'être, strategies, challenges and regulatory aspects.
    Mazahir F; Alam MI; Yadav AK
    Ageing Res Rev; 2024 Jul; 98():102318. PubMed ID: 38705362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine-driven therapeutic interventions of autophagy and stem cells in the management of Alzheimer's disease.
    Alhodieb FS; Rahman MA; Barkat MA; Alanezi AA; Barkat HA; Hadi HA; Harwansh RK; Mittal V
    Nanomedicine (Lond); 2023 Jan; 18(2):145-168. PubMed ID: 36938800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.
    Fonseca-Santos B; Gremião MP; Chorilli M
    Int J Nanomedicine; 2015; 10():4981-5003. PubMed ID: 26345528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon Dots: A Future Blood-Brain Barrier Penetrating Nanomedicine and Drug Nanocarrier.
    Zhang W; Sigdel G; Mintz KJ; Seven ES; Zhou Y; Wang C; Leblanc RM
    Int J Nanomedicine; 2021; 16():5003-5016. PubMed ID: 34326638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.